The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's Disease
about
Update on the treatment of Parkinson’s disease psychosis: role of pimavanserinImpairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical ImplicationsLow dose clozapine controls adult-onset psychosis associated with the neurogenic ataxia-retinitis pigmentosa (NARP) mutation.Pimavanserin, a novel antipsychotic for management of Parkinson's disease psychosis.
P2860
The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's Disease
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The Efficacy and Safety of Ant ...... ients with Parkinson's Disease
@ast
The Efficacy and Safety of Ant ...... ients with Parkinson's Disease
@en
The Efficacy and Safety of Ant ...... ients with Parkinson's Disease
@nl
type
label
The Efficacy and Safety of Ant ...... ients with Parkinson's Disease
@ast
The Efficacy and Safety of Ant ...... ients with Parkinson's Disease
@en
The Efficacy and Safety of Ant ...... ients with Parkinson's Disease
@nl
prefLabel
The Efficacy and Safety of Ant ...... ients with Parkinson's Disease
@ast
The Efficacy and Safety of Ant ...... ients with Parkinson's Disease
@en
The Efficacy and Safety of Ant ...... ients with Parkinson's Disease
@nl
P2093
P2860
P50
P3181
P356
P1476
The Efficacy and Safety of Ant ...... ients with Parkinson's Disease
@en
P2093
Aleksandar Damjanović
Milica Prostran
Radan Stojanović
P2860
P304
P3181
P356
10.1155/2016/4938154
P407
P5008
P577
2016-07-18T00:00:00Z